Fallon Wellness Pharmacy Recalls Prostaglandin Rx Injections Due to Sterility Concerns
Fallon Wellness Pharmacy is recalling 43 vials of Prostaglandin Rx injections in New York due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a risk of serious injury or death if the product is contaminated.
Plain-English summary
Fallon Wellness Pharmacy, L.L.C. is recalling 43 vials of Prostaglandin Rx injections. The product is available in five different concentrations: 10 mcg/mL, 22.5 mcg/mL, 45 mcg/mL, 60 mcg/mL, and 80 mcg/mL. The recall is being conducted because of a lack of assurance of sterility.
The affected product was distributed in New York. The recall includes specific lots with expiration dates ranging from April 12, 2015, to April 27, 2015. The FDA has classified this recall as Class II.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- Prostaglandin Rx, dispensed in 5 ml vials: 1) 10 mcg/mL Injection, 2) 22.5 mcg/mL Injection, 3) 45 mcg/mL Injection, 4) 60 mcg/mL Injection, 5) 80 mcg/mL Injection, Fallon Wellness Pharmacy, L.L.C., Latham, NY 12110
- Manufacturer
- Fallon Wellness Pharmacy, L.L.C.
- Category
- Drug — Injection
- Hazard
- Affected units
- 43
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot#: a) 10272014@1
- Exp 4/27/15
- b) 11042014@60
- Exp 4/12/15
- c) 11192014@43
- d) 12042014@32
- e) 12182014@46
- f) 12232014@8
- 12242014@16
- g) 12312014@40
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 10 recalled by Fallon Wellness Pharmacy, L.L.C. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Fallon Wellness Pharmacy, L.L.C.
See all →- SevereFallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- SevereFallon Wellness Pharmacy Recalls PAPA/PHEN/PROST Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- SevereFallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereFallon Wellness Pharmacy Recalls Methylcobalamin/B-Complex Injection Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereFallon Wellness Pharmacy Recalls Methylcobolamin Injections Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereFallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- SevereFallon Wellness Pharmacy Recalls PAPA/PHEN/PROST Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- SevereFallon Pharmacy Recalls Bevacizumab Syringes Due to Sterility Concerns
FDA (Drugs) · 2013-11-06
- SevereFDA Recalls Green Valley Drugs Progesterone Injection for Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereApothecary Shoppe Recalls Phenotolamine and Prostaglandin Vials Due to Sterility Concerns
FDA (Drugs) · 2016-10-12
- SeverePromise Pharmacy Recalls Dexpanthenol Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2019-02-20